Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib

Michael Mian, Norbert Pescosta, Stefania Badiali, Paola Cristina Cappelletto, Luigi Marcheselli, Stefano Luminari, Francesca Patriarca, Renato Zambello, Anna Pascarella, Giuseppe Tagariello, Alessandra Marabese, Patrizia Mondello, Atto Billio, Sergio Cortelazzo

Research output: Contribution to journalArticle

Original languageEnglish
JournalBritish Journal of Haematology
DOIs
Publication statusE-pub ahead of print - Nov 26 2018

Cite this

Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib. / Mian, Michael; Pescosta, Norbert; Badiali, Stefania; Cappelletto, Paola Cristina; Marcheselli, Luigi; Luminari, Stefano; Patriarca, Francesca; Zambello, Renato; Pascarella, Anna; Tagariello, Giuseppe; Marabese, Alessandra; Mondello, Patrizia; Billio, Atto; Cortelazzo, Sergio.

In: British Journal of Haematology, 26.11.2018.

Research output: Contribution to journalArticle

Mian, M, Pescosta, N, Badiali, S, Cappelletto, PC, Marcheselli, L, Luminari, S, Patriarca, F, Zambello, R, Pascarella, A, Tagariello, G, Marabese, A, Mondello, P, Billio, A & Cortelazzo, S 2018, 'Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib', British Journal of Haematology. https://doi.org/10.1111/bjh.15645
Mian, Michael ; Pescosta, Norbert ; Badiali, Stefania ; Cappelletto, Paola Cristina ; Marcheselli, Luigi ; Luminari, Stefano ; Patriarca, Francesca ; Zambello, Renato ; Pascarella, Anna ; Tagariello, Giuseppe ; Marabese, Alessandra ; Mondello, Patrizia ; Billio, Atto ; Cortelazzo, Sergio. / Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib. In: British Journal of Haematology. 2018.
@article{d9432647bebd4d42b76a3c22ac11b5f7,
title = "Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib",
author = "Michael Mian and Norbert Pescosta and Stefania Badiali and Cappelletto, {Paola Cristina} and Luigi Marcheselli and Stefano Luminari and Francesca Patriarca and Renato Zambello and Anna Pascarella and Giuseppe Tagariello and Alessandra Marabese and Patrizia Mondello and Atto Billio and Sergio Cortelazzo",
year = "2018",
month = "11",
day = "26",
doi = "10.1111/bjh.15645",
language = "English",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",

}

TY - JOUR

T1 - Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib

AU - Mian, Michael

AU - Pescosta, Norbert

AU - Badiali, Stefania

AU - Cappelletto, Paola Cristina

AU - Marcheselli, Luigi

AU - Luminari, Stefano

AU - Patriarca, Francesca

AU - Zambello, Renato

AU - Pascarella, Anna

AU - Tagariello, Giuseppe

AU - Marabese, Alessandra

AU - Mondello, Patrizia

AU - Billio, Atto

AU - Cortelazzo, Sergio

PY - 2018/11/26

Y1 - 2018/11/26

U2 - 10.1111/bjh.15645

DO - 10.1111/bjh.15645

M3 - Article

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -